FormDSignal
40

BioStem Technologies closes $3M raise in Florida biotech

Company raise · Closed · POMPANO BEACH, FL · Form D filed 2026-10-09

BioStem Technologies, a Florida-incorporated biotechnology company, closed a $3M offering under Regulation D exemption 6(b) on September 29, 2026. The raise drew two investors and is now fully subscribed.

operating_company

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

Jason MatuszewskiExecutive Officer, Director
Brandon PoeExecutive Officer
Andrew Van VurstExecutive Officer, Director
Barry HassettExecutive Officer
Katherine GorrellExecutive Officer
Kenneth WarringtonDirector
Mark GlickmanDirector
Rayna Lesser HannawayDirector
Jodi UngrodtDirector
Steven SonenreichDirector

Signed by Jason Matuszewski, Chief Executive Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer